Análisis de la investigación española sobre cáncer de mama a través de la Web of Science (1900-2020)
Loading...
Download
Official URL
Full text at PDC
Publication date
2024
Defense date
04/07/2023
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citations
Exportar
Citation
Abstract
El cáncer de mama es un tipo de cáncer metastásico de carácter heterogéneo, con una amplia variación en la morfología del tumor, las características moleculares y la respuesta clínica. En muchos países con atención médica avanzada, la tasa de supervivencia a cinco años de los cánceres de mama en etapa temprana es del 80-90 %, disminuyendo al 24% para los cánceres de mama diagnosticados en una etapa más avanzada, lo que indica una necesidad crítica de mejorar el tratamiento de la enfermedad metastásica. Aunque la tasa de incidencia del cáncer de mama aumenta año tras año, la tasa de mortalidad disminuye gracias a las pruebas de detección precoz y las terapias médicas avanzadas. En los últimos años se han desarrollado terapias biológicas que han demostrado ser beneficiosas para el cáncer de mama. El progreso de la investigación médica se ha acompañado de un gran aumento de la financiación de la investigación y de la asignación de recursos, que en el caso del cáncer de mama ha sido uno de los campos en los que más se ha incrementado, incluso por encima de otros tipos de cáncer...
Breast cancer is a heterogeneous type of metastatic cancer, with wide variation in tumour morphology, molecular characteristics and clinical response. In many countries with advanced medical care, the five-year survival rate for early-stage breast cancers is 80-90%, decreasing to 24% for breast cancers diagnosed at a more advanced stage, indicating a critical need for improved treatment of metastatic disease. Although the incidence rate of breast cancer is increasing over the years, the mortality rate is decreasing thanks to early detection screening and advanced medical therapies. In recent years, biological therapies have been developed that have shown to be beneficial for breast cancer. Progress in medical research has been accompanied by a large increase in research funding and resource allocation, which in the case of breast cancer has been one of the fields in which it has increased the most, even above other types of cancer...
Breast cancer is a heterogeneous type of metastatic cancer, with wide variation in tumour morphology, molecular characteristics and clinical response. In many countries with advanced medical care, the five-year survival rate for early-stage breast cancers is 80-90%, decreasing to 24% for breast cancers diagnosed at a more advanced stage, indicating a critical need for improved treatment of metastatic disease. Although the incidence rate of breast cancer is increasing over the years, the mortality rate is decreasing thanks to early detection screening and advanced medical therapies. In recent years, biological therapies have been developed that have shown to be beneficial for breast cancer. Progress in medical research has been accompanied by a large increase in research funding and resource allocation, which in the case of breast cancer has been one of the fields in which it has increased the most, even above other types of cancer...
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Enfermería, Fisioterapia y Podología, leída el 04-07-2023